Leslie S Massad1, Xianhong Xie, Howard Minkoff, Seble Kassaye, Roksana Karim, Teresa M Darragh, Elizabeth T Golub, Adaora Adimora, Gina Wingood, Margaret Fischl, Deborah Konkle-Parker, Howard D Strickler. 1. Division of Gynecologic Oncology, Washington University School of Medicine, St. Louis, Missouri Albert Einstein College of Medicine, Bronx Maimonides Medical Center, Brooklyn, New York Georgetown University School of Medicine, Washington, DC University of Southern California, Los Angeles University of California, San Francisco, California Johns Hopkins University, Baltimore, Maryland University of North Carolina, Chapel Hill, North Carolina Mailman School of Public Health, Columbia University, New York, New York University of Miami, Miami, Florida University of Mississippi, Jackson, Mississippi, USA.
Abstract
OBJECTIVE: To describe longitudinal changes in the prevalence of abnormal Papanicolau testing among women living with HIV. DESIGN: Prospective cohort study with sequential enrollment subcohorts. METHODS: Four waves of enrollment occurred in the Women's Interagency HIV Study, the US women's HIV cohort (1994-1995, 2001-2002, 2011-2012, 2013-2015). Pap testing was done at intake, with colposcopy prescribed for any abnormality. Rates of abnormal Pap test results (atypical squamous cells of uncertain significance or worse) and cervical intraepithelial neoplasia grade 2 (CIN2) or worse were calculated. Logistic regression models assessed changes in prevalence across cohorts after controlling for severity of HIV disease and other risk factors for abnormal Pap tests. RESULTS: The unadjusted prevalence of any Pap abnormality was 679/1769 (38%) in the original cohort, 195/684 (29%) in the 2001-2002 cohort, 46/231 (20%) in the 2011-2012 cohort, and 71/449 (16%) in the 2013-2015 cohort. In multivariable analysis, compared with risk in the 1994-1995 cohort, the adjusted risk in the 2001-2002 cohort was 0.79 (95% CI 0.59-1.05), in the 2011-2012 cohort was 0.67 (95% CI 0.43-1.04), and in the 2013-2015 cohort was 0.41 (95% CI 0.27-0.62) with P for trend less than 0.0001. CONCLUSION: Rates of abnormal cytology among women with HIV have fallen during the past two decades.
OBJECTIVE: To describe longitudinal changes in the prevalence of abnormal Papanicolau testing among women living with HIV. DESIGN: Prospective cohort study with sequential enrollment subcohorts. METHODS: Four waves of enrollment occurred in the Women's Interagency HIV Study, the US women's HIV cohort (1994-1995, 2001-2002, 2011-2012, 2013-2015). Pap testing was done at intake, with colposcopy prescribed for any abnormality. Rates of abnormal Pap test results (atypical squamous cells of uncertain significance or worse) and cervical intraepithelial neoplasia grade 2 (CIN2) or worse were calculated. Logistic regression models assessed changes in prevalence across cohorts after controlling for severity of HIV disease and other risk factors for abnormal Pap tests. RESULTS: The unadjusted prevalence of any Pap abnormality was 679/1769 (38%) in the original cohort, 195/684 (29%) in the 2001-2002 cohort, 46/231 (20%) in the 2011-2012 cohort, and 71/449 (16%) in the 2013-2015 cohort. In multivariable analysis, compared with risk in the 1994-1995 cohort, the adjusted risk in the 2001-2002 cohort was 0.79 (95% CI 0.59-1.05), in the 2011-2012 cohort was 0.67 (95% CI 0.43-1.04), and in the 2013-2015 cohort was 0.41 (95% CI 0.27-0.62) with P for trend less than 0.0001. CONCLUSION: Rates of abnormal cytology among women with HIV have fallen during the past two decades.
Authors: Melanie C Bacon; Viktor von Wyl; Christine Alden; Gerald Sharp; Esther Robison; Nancy Hessol; Stephen Gange; Yvonne Barranday; Susan Holman; Kathleen Weber; Mary A Young Journal: Clin Diagn Lab Immunol Date: 2005-09
Authors: Amy Lansky; John T Brooks; Elizabeth DiNenno; James Heffelfinger; H Irene Hall; Jonathan Mermin Journal: J Acquir Immune Defic Syndr Date: 2010-12 Impact factor: 3.731
Authors: Laura L Reimers; Supriya D Mehta; L Stewart Massad; Robert D Burk; Xianhong Xie; Jacques Ravel; Mardge H Cohen; Joel M Palefsky; Kathleen M Weber; Xiaonan Xue; Kathryn Anastos; Howard Minkoff; Jessica Atrio; Gypsyamber D'Souza; Qian Ye; Christine Colie; Christine P Zolnik; Gregory T Spear; Howard D Strickler Journal: J Infect Dis Date: 2016-08-11 Impact factor: 5.226
Authors: Pangaja Paramsothy; Denise J Jamieson; Charles M Heilig; Paula C Schuman; Robert S Klein; Keerti V Shah; Anne M Rompalo; Susan Cu-Uvin; Ann Duerr Journal: Obstet Gynecol Date: 2009-01 Impact factor: 7.661
Authors: L Stewart Massad; Eric C Seaberg; Rodney L Wright; Teresa Darragh; Yi-Chun Lee; Christine Colie; Robert Burk; Howard D Strickler; D Heather Watts Journal: Obstet Gynecol Date: 2008-06 Impact factor: 7.661
Authors: Howard Minkoff; Ye Zhong; Robert D Burk; Joel M Palefsky; Xiaonan Xue; D Heather Watts; Alexandra M Levine; Rodney L Wright; Christine Colie; Gypsyamber D'Souza; L Stewart Massad; Howard D Strickler Journal: J Infect Dis Date: 2010-03 Impact factor: 5.226
Authors: Adaora A Adimora; Catalina Ramirez; Lorie Benning; Ruth M Greenblatt; Mirjam-Colette Kempf; Phyllis C Tien; Seble G Kassaye; Kathryn Anastos; Mardge Cohen; Howard Minkoff; Gina Wingood; Igho Ofotokun; Margaret A Fischl; Stephen Gange Journal: Int J Epidemiol Date: 2018-04-01 Impact factor: 7.196
Authors: A Benlahrech; A Yasmin; S J Westrop; A Coleman; A Herasimtschuk; E Page; P Kelleher; F Gotch; N Imami; S Patterson Journal: Clin Exp Immunol Date: 2012-11 Impact factor: 4.330
Authors: L Stewart Massad; Elizabeth M Daubert; Charlesnika T Evans; Howard Minkoff; Seble Kassaye; Jodie Dionne-Odom; Dominika Seidman; Kerry Murphy; Maria L Alcaide; Adaora A Adimora; Anandi N Sheth; Elizabeth T Golub; Audrey L French; Kathleen M Weber Journal: J Womens Health (Larchmt) Date: 2021-08-27 Impact factor: 3.017
Authors: L Stewart Massad; Xianhong Xie; Howard L Minkoff; Katherine G Michel; Gypsyamber D'Souza; Chia-Ching Wang; Deborah Konkle-Parker; Igho Ofotokun; Margaret A Fischl; Lisa Rahangdale; Howard D Strickler Journal: Am J Obstet Gynecol Date: 2021-05-03 Impact factor: 10.693
Authors: Howard D Strickler; Marla J Keller; Nancy A Hessol; Isam-Eldin Eltoum; Mark H Einstein; Philip E Castle; L Stewart Massad; Lisa Flowers; Lisa Rahangdale; Jessica M Atrio; Catalina Ramirez; Howard Minkoff; Adaora A Adimora; Igho Ofotokun; Christine Colie; Megan J Huchko; Margaret Fischl; Rodney Wright; Gypsyamber D'Souza; Jason Leider; Olga Diaz; Lorraine Sanchez-Keeland; Sadeep Shrestha; Xianhong Xie; Xiaonan Xue; Kathryn Anastos; Joel M Palefsky; Robert D Burk Journal: Clin Infect Dis Date: 2021-05-04 Impact factor: 9.079